What is BioCryst Pharmaceuticals's tax on share settlement?

BioCryst Pharmaceuticals (BCRX) reported tax on share settlement of $1.19M in Q1 2026.

How has BioCryst Pharmaceuticals's tax on share settlement changed year-over-year?

BioCryst Pharmaceuticals's tax on share settlement decreased by 12.1% year-over-year, from $1.35M to $1.19M.

What does tax on share settlement mean?

Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.

BioCryst Pharmaceuticals BCRX Tax on Share Settlement

Tax on Share Settlement at other companies

AnaptysBio, Inc.ANAB

$0-100%

BridgeBio PharmaBBIO

$4.07M+129%

PrecigenPGEN

$146K-69.2%

Amneal Pharmaceuticals, Inc.AMRX

$44.31M+105%

Regeneron PharmaceuticalsREGN

$73.2M+1,602%

Halozyme TherapeuticsHALO

——

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's tax on share settlement?: BioCryst Pharmaceuticals (BCRX) reported tax on share settlement of $1.19M in Q1 2026.
How has BioCryst Pharmaceuticals's tax on share settlement changed year-over-year?: BioCryst Pharmaceuticals's tax on share settlement decreased by 12.1% year-over-year, from $1.35M to $1.19M.
What does tax on share settlement mean?: Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.